Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Current Leases (2019 - 2025)

AC Immune (ACIU) has disclosed Current Leases for 6 consecutive years, with $1.2 million as the latest value for Q4 2024.

  • On a quarterly basis, Current Leases rose 54.6% to $1.2 million in Q4 2024 year-over-year; TTM through Dec 2024 was $1.2 million, a 54.6% increase, with the full-year FY2024 number at $1.2 million, up 56.53% from a year prior.
  • Current Leases was $1.2 million for Q4 2024 at AC Immune, up from $757582.2 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.2 million in Q4 2024 to a low of $490026.9 in Q4 2020.
  • A 5-year average of $721162.6 and a median of $618166.2 in 2021 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: fell 7.98% in 2022, then skyrocketed 54.6% in 2024.
  • AC Immune's Current Leases stood at $490026.9 in 2020, then increased by 26.15% to $618166.2 in 2021, then dropped by 7.98% to $568836.0 in 2022, then soared by 33.18% to $757582.2 in 2023, then surged by 54.6% to $1.2 million in 2024.
  • Per Business Quant, the three most recent readings for ACIU's Current Leases are $1.2 million (Q4 2024), $757582.2 (Q4 2023), and $568836.0 (Q4 2022).